- Home
- IMNM vs IRS Comparison
IMNM vs IRS Comparison
Compare IMNM & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- IRS
- Stock Information
- Founded
- IMNM 2006
- IRS 1943
- Country
- IMNM United States
- IRS Argentina
- Employees
- IMNM N/A
- IRS N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- IRS Homebuilding
- Sector
- IMNM Health Care
- IRS Real Estate
- Exchange
- IMNM Nasdaq
- IRS Nasdaq
- Market Cap
- IMNM 945.8M
- IRS 959.8M
- IPO Year
- IMNM 2020
- IRS 1994
- Fundamental
- Price
- IMNM $9.69
- IRS $12.34
- Analyst Decision
- IMNM Strong Buy
- IRS
- Analyst Count
- IMNM 8
- IRS 0
- Target Price
- IMNM $24.75
- IRS N/A
- AVG Volume (30 Days)
- IMNM 756.6K
- IRS 279.4K
- Earning Date
- IMNM 08-06-2025
- IRS 11-05-2025
- Dividend Yield
- IMNM N/A
- IRS 7.97%
- EPS Growth
- IMNM N/A
- IRS N/A
- EPS
- IMNM N/A
- IRS 0.20
- Revenue
- IMNM $12,589,000.00
- IRS $393,157,502.00
- Revenue This Year
- IMNM N/A
- IRS N/A
- Revenue Next Year
- IMNM $154.73
- IRS N/A
- P/E Ratio
- IMNM N/A
- IRS $5.98
- Revenue Growth
- IMNM 16.74
- IRS 29.22
- 52 Week Low
- IMNM $5.15
- IRS $10.61
- 52 Week High
- IMNM $16.73
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- IMNM 48.73
- IRS 31.77
- Support Level
- IMNM $8.67
- IRS $11.33
- Resistance Level
- IMNM $9.71
- IRS $13.34
- Average True Range (ATR)
- IMNM 0.63
- IRS 0.76
- MACD
- IMNM -0.04
- IRS -0.24
- Stochastic Oscillator
- IMNM 51.64
- IRS 27.08
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.